Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Clinical Significance of Pancreatic Atrophy Induced by Immune-Checkpoint Inhibitors: A Case-Control Study.

Eshet Y, Baruch EN, Shapira-Frommer R, Steinberg-Silman Y, Kuznetsov T, Ben-Betzalel G, Daher S, Gluck I, Asher N, Apter S, Schachter J, Bar J, Boursi B, Markel G.

Cancer Immunol Res. 2018 Dec;6(12):1453-1458. doi: 10.1158/2326-6066.CIR-17-0659. Epub 2018 Oct 1.

PMID:
30275274
2.

Possible immune adverse events as predictors of durable response to BRAF inhibitors in patients with BRAF V600-mutant metastatic melanoma.

Ben-Betzalel G, Baruch EN, Boursi B, Steinberg-Silman Y, Asher N, Shapira-Frommer R, Schachter J, Markel G.

Eur J Cancer. 2018 Sep;101:229-235. doi: 10.1016/j.ejca.2018.06.030. Epub 2018 Aug 7.

PMID:
30096703
3.

ADAR1-mediated regulation of melanoma invasion.

Nemlich Y, Baruch EN, Besser MJ, Shoshan E, Bar-Eli M, Anafi L, Barshack I, Schachter J, Ortenberg R, Markel G.

Nat Commun. 2018 May 31;9(1):2154. doi: 10.1038/s41467-018-04600-2.

4.

Histopathological expression analysis of intercellular adhesion molecule 1 (ICAM-1) along development and progression of human melanoma.

Galore-Haskel G, Baruch EN, Berg AL, Barshack I, Zilinsky I, Avivi C, Besser MJ, Schachter J, Markel G.

Oncotarget. 2017 Sep 14;8(59):99580-99586. doi: 10.18632/oncotarget.20884. eCollection 2017 Nov 21.

5.

Prehospital administration of freeze-dried plasma, is it the solution for trauma casualties?

Shlaifer A, Siman-Tov M, Radomislensky I, Peleg K, Shina A, Baruch EN, Glassberg E, Yitzhak A; ITG*.

J Trauma Acute Care Surg. 2017 Oct;83(4):675-682. doi: 10.1097/TA.0000000000001569.

PMID:
28930960
6.

Adoptive T cell therapy: An overview of obstacles and opportunities.

Baruch EN, Berg AL, Besser MJ, Schachter J, Markel G.

Cancer. 2017 Jun 1;123(S11):2154-2162. doi: 10.1002/cncr.30491. Review.

7.

Extending a Helping Hand: A Comparison of Israel Defense Forces Medical Corps Humanitarian Aid Field Hospitals.

Glick Y, Baruch EN, Tsur AM, Berg AL, Yifrah D, Yitzhak A, Dagan D, Bader T.

Isr Med Assoc J. 2016 Oct;18(10):581-585.

8.

Point of injury tourniquet application during Operation Protective Edge-What do we learn?

Shlaifer A, Yitzhak A, Baruch EN, Shina A, Satanovsky A, Shovali A, Almog O, Glassberg E.

J Trauma Acute Care Surg. 2017 Aug;83(2):278-283. doi: 10.1097/TA.0000000000001403.

PMID:
28230629
9.

Comparison of Two Intraosseous Devices: The NIO Versus the EZ-IO by Novice Users-A Randomized Cross Over Trial.

Shina A, Baruch EN, Shlaifer A, Shovali A, Levi M, Yosefy O, Segal D, Bader T, Shavit I, Yitzhak A.

Prehosp Emerg Care. 2017 May-Jun;21(3):315-321. doi: 10.1080/10903127.2016.1247201. Epub 2016 Nov 21.

PMID:
27870553
10.

Does practice make perfect? Prospectively comparing effects of 2 amounts of practice on tourniquet use performance.

Baruch EN, Benov A, Shina A, Berg AL, Shlaifer A, Glassberg E, Aden JK 3rd, Bader T, Kragh JF Jr, Yitzhak A.

Am J Emerg Med. 2016 Dec;34(12):2356-2361. doi: 10.1016/j.ajem.2016.08.048. Epub 2016 Aug 27.

PMID:
27614373
11.

Confidence-Competence Mismatch and Reasons for Failure of Non-Medical Tourniquet Users.

Baruch EN, Kragh JF Jr, Berg AL, Aden JK Rd, Benov A, Shina A, Shlaifer A, Ahimor A, Glassberg E, Yitzhak A.

Prehosp Emerg Care. 2017 Jan-Feb;21(1):39-45. doi: 10.1080/10903127.2016.1209261. Epub 2016 Aug 5.

PMID:
27494564
12.

Augmentation of point of injury care: Reducing battlefield mortality-The IDF experience.

Benov Avi, Elon G, Baruch EN, Avi S, Gilad T, Moran L, Itay Z, Ram S, Tarif B, David D, Avraham Y, Yitshak K.

Injury. 2016 May;47(5):993-1000. doi: 10.1016/j.injury.2015.10.078. Epub 2015 Nov 18.

PMID:
26725147

Supplemental Content

Loading ...
Support Center